These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2516711)

  • 41. The current status of malignant hyperthermia.
    Yang L; Tautz T; Zhang S; Fomina A; Liu H
    J Biomed Res; 2019 May; 34(2):75-85. PubMed ID: 32305961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Registration of peranesthetic cases of malignant hyperthermia in France. An update].
    Jacquot C; Stieglitz P; Kozak-Reiss G; Krivosic-Horber R; Laxenaire MC; Lienhart A; Nivoche Y
    Ann Fr Anesth Reanim; 1988; 7(6):524-34. PubMed ID: 3223647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The incidence of masseter muscle rigidity after succinylcholine in infants and children.
    Lazzell VA; Carr AS; Lerman J; Burrows FA; Creighton RE
    Can J Anaesth; 1994 Jun; 41(6):475-9. PubMed ID: 8069986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil].
    Almeida da Silva HC; Ferreira G; Rodrigues G; Santos JMD; Andrade PV; Hortense A; Vaz Perez M; Amaral JLGD
    Braz J Anesthesiol; 2019; 69(2):152-159. PubMed ID: 30935497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Malignant hyperthermia].
    Urwyler A; Hartung E
    Anaesthesist; 1994 Aug; 43(8):557-69. PubMed ID: 7978181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
    Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB
    Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant hyperthermia susceptibility in adult patients with masseter muscle rigidity.
    Allen GC; Rosenberg H
    Can J Anaesth; 1990 Jan; 37(1):31-5. PubMed ID: 2295104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
    Mortier W; Breucking E
    Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant hyperthermia when dantrolene is not readily available.
    Gong X
    BMC Anesthesiol; 2021 Apr; 21(1):119. PubMed ID: 33863282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
    Blank JW; Boggs SD
    J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anaesthesia and progressive muscular dystrophy.
    Smith CL; Bush GH
    Br J Anaesth; 1985 Nov; 57(11):1113-8. PubMed ID: 4052303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fatigue, depression, and physical activity in patients with malignant hyperthermia: a cross-sectional observational study.
    Andrade PMV; Valim LÍM; Santos JMD; Castro I; Amaral JLGD; Silva HCAD
    Braz J Anesthesiol; 2023; 73(2):132-137. PubMed ID: 34626754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Malignant hyperthermia in children: an analysis of the North American malignant hyperthermia registry.
    Nelson P; Litman RS
    Anesth Analg; 2014 Feb; 118(2):369-374. PubMed ID: 24299931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant hyperthermia: a review.
    Rosenberg H; Pollock N; Schiemann A; Bulger T; Stowell K
    Orphanet J Rare Dis; 2015 Aug; 10():93. PubMed ID: 26238698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
    Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
    Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
    Sudo RT; Cunha LB; Carmo PL; Matos AR; Trachez MM; Cardoso LA; Aguiar MI; Abreu AV; Zapata-Sudo G
    Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Anesthetic complications. The incidence of severe anesthetic complications in patients and families with progressive muscular dystrophy of the Duchenne and Becker types].
    Breucking E; Reimnitz P; Schara U; Mortier W
    Anaesthesist; 2000 Mar; 49(3):187-95. PubMed ID: 10788987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cardiac arrest during anesthesia induction with halothane and succinylcholine in an infant. Massive hyperkalemia and rhabdomyolysis in suspected myopathy and/or malignant hyperthermia].
    Mehler J; Bachour H; Simons F; Wolpers K
    Anaesthesist; 1991 Sep; 40(9):497-501. PubMed ID: 1952045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia.
    Litman RS; Smith VI; Larach MG; Mayes L; Shukry M; Theroux MC; Watt S; Wong CA
    Anesth Analg; 2019 Apr; 128(4):652-659. PubMed ID: 30768455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignant hyperthermia in plastic surgery.
    Wackym PA; Dubrow TJ; Abdul-Rasool IH; Lesavoy MA
    Plast Reconstr Surg; 1988 Nov; 82(5):878-82. PubMed ID: 3174876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.